DGPPN

What DGPPN does

DGPPN (Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde e.V.) is Germany's foremost medical-scientific professional society for psychiatry, psychotherapy, psychosomatics, and neurology, founded in 1842 and headquartered in Berlin. The organization functions as the national authority and convener for the German psychiatric community, serving psychiatrists, psychotherapists, researchers, and allied health professionals through a portfolio anchored by evidence-based S3 clinical guidelines, the annual DGPPN Kongress (Europe's largest mental health congress, ~9,000–9,600 participants in 2025), the Psyche im Fokus magazine, specialty journals and books, the Patientenverfügung mental health advance directive, the DGPPN Akademie continuing-education platform, and an awards program distributing over 100,000 EUR annually. It also engages in public-facing anti-stigma campaigns (Generation PSY, Die Psychiater) and convenes the Aktionsbündnis Seelische Gesundheit alliance.

The society is a non-profit registered association (eingetragener Verein / e.V.) with 11–50 staff, generating revenue primarily through differentiated membership dues (including a 'Starter' tier for early-career professionals), congress registration and sponsorship, publication sales, and grants. Its go-to-market is community-led: it reaches its audience through the annual congress, member portal and app, DGPPN Akademie, press releases, LinkedIn, and public awareness weeks (Woche der Seelischen Gesundheit). Its customer base spans three horizontal segments — practicing psychiatrists/psychotherapists (primary), policymakers and health authorities, and the general public — with no single-customer concentration.

Underlying platform and infrastructure are content- and event-centric rather than technology-centric. The DGPPN member portal and DGPPN App deliver publications, guidelines, and a job board to members, but the organization does not develop proprietary technology products, AI/ML models, or APIs. Strategic activity in 2024–2026 has centered on intensive S3 guideline publication (six major updates in 2026 alone), inter-society collaboration (DG-Sucht, DGKJP, DGN, DGPM), international policy engagement (European Brain Council, PRAGUE-Agreement), and aggressive advocacy on German health reform legislation.

Name

DGPPN

Legal name

Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde e. V.

Website

https://dgppn.de

Company type

Private

Founded year

1842

Operating status

Operating

Headcount range

10,001+ employees

Short description

DGPPN is Germany's primary medical-scientific professional society for psychiatry and psychotherapy, serving psychiatrists, psychotherapists, and policymakers through S3 clinical guidelines, the annual DGPPN Kongress, publications, and policy advocacy since 1842.

Ownership category

akta.pro rank

Product category

Professional Medical Society / Medical-Scientific Association

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Health Services (8000)

akta.pro primary industry

Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)

Keywords

• Psychiatric professional society
• Clinical mental health guidelines
• Medical continuing education
• Psychotherapy advocacy
• Mental health congress

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership dues: DGPPN generates revenue through membership fees, with differentiated plans including a standard membership and a 'Starter' membership tier for early-career professionals.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels9 records

Core offering

DGPPN is Germany's leading medical-scientific professional society for psychiatry, psychotherapy, psychosomatics, and neurology. It operates as a membership-based association that delivers clinical S3 guidelines, an annual congress (Europe's largest in mental health), continuing education through the DGPPN Akademie, scientific publications including the Psyche im Fokus magazine, policy advocacy, position papers, and an awards program totaling approximately 100,000 EUR annually.

Product overview

DGPPN (Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde e.V.) is Germany's leading medical-scientific professional society for psychiatry and psychotherapy. The organization functions as a professional society rather than a technology product company. Its core offerings include clinical S3 guidelines for psychiatric conditions, scientific publications (Psyche im Fokus magazine), the annual DGPPN Kongress (Europe's largest mental health congress), the DGPPN Akademie for continuing education, a mobile application, patient resources such as advance directives for mental health, and a awards program totaling approximately 99,000-110,000 EUR annually. The society also issues position papers and statements on healthcare policy, mental health surveillance, and clinical recommendations.

Differentiator

Problem solved

Functional benefit

Brands

• Generation PSY: A digital campaign by DGPPN targeting young people to counteract clichés about mental illness and the psychiatric profession.
• Trialogisches Forum
• DGPPN Akademie
• DGPPN Kongress
• Psyche im Fokus
• Die Psychiater
• Teilhabekompass

Products and services

• DGPPN App Mobile application providing members access to DGPPN publications, news, and clinical guidelines on psychiatry and psychotherapy.
• Psyche im Fokus Official DGPPN magazine featuring articles, interviews, and scientific updates on mental health, psychiatry, psychotherapy, and health policy for professionals and informed public.
• DGPPN Kongress Europe's largest specialized congress in mental health, offering scientific lectures, workshops, and networking opportunities for psychiatry and psychotherapy professionals.
• DGPPN Akademie Educational platform offering professional development, training, and continuing education events with CME credits for psychiatrists and psychotherapists.
• Leitlinien (Clinical Guidelines) S3-level clinical guidelines developed by DGPPN covering psychiatric conditions including schizophrenia, dementia, psychosis with comorbid substance disorders, psychosocial therapies, and prevention of coercion.
• Patientenverfügung (Living Will for Mental Health) A specially developed advance directive form for mental health enabling patients to make decisions about treatment in case of reduced capacity for consent.
• DGPPN Preise und Auszeichnungen (Awards Program) Prize program honoring outstanding research, projects, and media reporting on mental health, with total prize money of approximately 99,000-110,000 EUR annually across multiple categories.
• Generation PSY Junior initiative running campaigns to educate about psychiatry and psychotherapy and combat clichés about mental illness and the psychiatrist profession, targeting young people.

Quantifiable outcome

• 9,600+ mental health professionals reached annually through the DGPPN Kongress
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Ten partnerships are on record, tiered minor and core.

• PRAGUE-AgreementminorStrategic or Co-development Partner · 19 January 2026DGPPN signed the PRAGUE-Agreement, an international initiative calling on financial system actors to prioritize investment in population mental health as a prerequisite for economic development.
• Deutsche Gesellschaft für Suchtforschung und Suchttherapie (DG-Sucht)coreStrategic or Co-development Partner · 22 October 2025DGPPN and DG-Sucht jointly publish clinical guidelines (S3 Leitlinien), including the guideline on 'Psychosen mit komorbider substanzbezogener Störung' (psychoses with comorbid substance use disorder). The two societies also issue joint position statements on cannabis policy, addiction, and related topics.
• Deutsche Gesellschaft für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (DGKJP)coreStrategic or Co-development Partner · 10 October 2025DGPPN and DGKJP collaborate on joint position statements and guidelines, including responses to the EKOCAN cannabis evaluation report and shared advocacy on child and adolescent mental health policy.
• Deutsche Gesellschaft für Neurologie (DGN)coreStrategic or Co-development Partner · 10 October 2025DGPPN and DGN jointly produce the Living Guideline Demenzen (dementia guidelines) and related position papers on neurological-psychiatric topics. They also collaborate on Alzheimer antibody therapy assessments (Lecanemab, Donanemab).
• European Brain Council (EBC)coreStrategic or Co-development Partner · 12 September 2024DGPPN actively supports the European Brain Council's 'No Health Without Brain Health' initiative and its 'Towards an EU Coordination Plan for the Brain'. The partnership aims to elevate brain health on the EU health and research agenda.
• Deutsche Gesellschaft für Psychosomatische Medizin und Ärztliche Psychotherapie (DGPM)coreStrategic or Co-development Partner · 6 April 2024DGPPN and DGPM jointly published a position paper on Post-COVID Syndrome (PCS), advocating for interdisciplinary care, stronger research, and improved participation for affected individuals.
• European Psychiatric Association (EPA)minorStrategic or Co-development Partner · 30 October 2023DGPPN supports the EPA manifesto calling for pan-European improvements in mental health care, particularly regarding democratic engagement ahead of the 2024 European Parliament elections.
• 200+ health sector organizations (joint declaration on democracy and pluralism)minorStrategic or Co-development Partner · 18 March 2023DGPPN co-signed the 'Demokratie und Pluralismus als Fundament für ein menschliches Gesundheitswesen' declaration alongside over 200 health sector organizations, advocating for democratic values and pluralism in healthcare.
• Aktionsbündnis Seelische Gesundheit (Mental Health Action Alliance)coreStrategic or Co-development Partner · 10 October 2019DGPPN is a founding member of the Aktionsbündnis Seelische Gesundheit, which coordinates the annual Woche der Seelischen Gesundheit (Week of Mental Health), a nationwide awareness campaign involving 500+ events and coordinated by over 200 member organizations.
• Plattform Entgelt (Remuneration Platform)coreStrategic or Co-development Partner · 18 September 2019DGPPN participates in the Plattform Entgelt, a coalition of psychiatric professional societies and associations that issues joint position papers on hospital remuneration and staffing regulations affecting psychiatric care in Germany.

Scale indicators5 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• European Psychiatric Association (EPA): Pan-European professional society for psychiatry that issues position papers, hosts the European Congress of Psychiatry, and represents European psychiatrists. Directly comparable to DGPPN in mission (guideline advocacy, congresses, education) but operates at the European rather than national level.
• Deutsche Gesellschaft für Suchtforschung und Suchttherapie (DG-Sucht): German addiction-research and addiction-therapy society that co-develops S3 guidelines and joint position statements with DGPPN. Closely comparable in structure, scale, and operating model as a German specialty medical society.
• Deutsche Gesellschaft für Psychosomatische Medizin und Ärztliche Psychotherapie (DGPM): German professional society for psychosomatic medicine and medical psychotherapy, co-authoring position papers (e.g., Post-COVID Syndrome) with DGPPN. Operationally comparable as a German specialty society within the same mental-health ecosystem.
• Deutsche Gesellschaft für Neurologie (DGN): German neurological professional society that jointly produces the Living Guideline Demenzen and collaborates with DGPPN on antibody therapy assessments. Highly comparable as a German specialty society with shared governance, congress, and guideline-publication functions.
• Deutsche Gesellschaft für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (DGKJP): German professional society for child and adolescent psychiatry with which DGPPN co-publishes position papers and guidelines. Directly comparable as a German specialty medical society with overlapping governance, congress, and guideline-development activities.
• Royal College of Psychiatrists (RCPsych): UK professional body for psychiatrists that sets clinical standards, runs the International Congress, issues position statements, and accredits training. Directly comparable to DGPPN in operating model (national membership society + guidelines + congress + advocacy) but geographically UK-focused.

Emerging players

• Deutsche Gesellschaft für Psychologie (DGPs): Germany's primary scientific psychology society, addressing psychotherapy-related issues from a research-psychology rather than medical-psychiatry perspective. Adjacent peer that competes for science-policy attention in the mental-health space.
• Bundespsychotherapeutenkammer (BPtK): Federal chamber representing psychotherapists in Germany, advocating for the psychotherapy profession on policy and reimbursement matters. Adjacent competitor for policy influence within the broader German mental-health ecosystem.

Broad incumbents

• World Psychiatric Association (WPA): Global psychiatric professional society that partners with national societies (including DGPPN-aligned European ones) and organizes the World Congress of Psychiatry. Comparable governance, congress, and guideline-publication model at global scale.
• American Psychiatric Association (APA): The largest national psychiatric professional society globally, producing the DSM, hosting the Annual Meeting, and publishing American Journal of Psychiatry. Comparable structure to DGPPN across guidelines, publishing, congress, and advocacy but at significantly greater scale and with greater commercial publishing footprint.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/dgppn
• LinkedInlinkedin.com/company/dgppn
• Instagraminstagram.com/dgppn
• Facebookfacebook.com/dgppn

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DGPPN